SAN FRANCISCO and NOIDA, INDIA – Oct. 19, 2021 – HCL Technologies (HCL), a leading global technology company and Innovaccer Inc., a health cloud company, announced today a collaboration to help healthcare and life sciences organizations drive digital health transformation.
The partnership will help improve population health, value-based care, connected health, patient-physician engagement and other industry imperatives by ingesting, aggregating, and normalizing healthcare data from disparate sources to improve data quality and health outcomes.
Innovaccer’s rich set of capabilities, including scalable fast healthcare interoperability resource (FHIR) APIs and an optimized data lake, allow organizations to use data analytics, AI, and machine learning to generate actionable insights at the point of care. HCL uses its next-generation digital and data transformation capabilities to help healthcare enterprises unlock the full potential of siloed -- and often complex -- data using Innovaccer’s Data Activation Platform and analytics-driven applications.
By combining Innovaccer’s Data Activation Platform with HCL’s robust healthcare data accelerator (hDATA) suite, organizations can enable patient-centricity, cost-optimization and compliance.
“Our partnership with Innovaccer will further enable us to help our clients catalyze their digital journeys and enhance overall quality, confidence, and speed of delivering data solutions for our healthcare and life sciences clients,” said Shrikanth Shetty, Corporate Vice President and Head of Life Sciences and Healthcare, HCL Technologies. “We look forward to working with Innovaccer to speed up implementation and integration timelines and quickly deliver value to our clients.”
“HCL Technologies and Innovaccer share a common vision: creating a future built on pervasive collaboration,” said Abhinav Shashank, CEO at Innovaccer. “We’re laying the foundation to help our customers and partners drive their digital transformations and realize our shared mission of bringing all healthcare data and stakeholders together to serve patients and enable truly holistic care.”
About HCL Technologies
HCL Technologies (HCL) empowers global enterprises with technology for the next decade, today. HCL’s Mode 1-2-3 strategy, based on its deep-domain industry expertise, client-centricity and entrepreneurial culture of Ideapreneurship™, enables businesses to transform into next-gen enterprises.
HCL offers its services and products through three business units: IT and Business Services (ITBS), Engineering and R&D Services (ERS) and Products & Platforms (P&P). ITBS enables global enterprises to transform their businesses through offerings in the areas of applications, infrastructure, digital process operations and next-generation digital transformation solutions. ERS offers engineering services and solutions in all aspects of product development and platform engineering. P&P provides modernized software products to global clients for their technology and industry-specific requirements. Through its cutting-edge co-innovation labs, global delivery capabilities and broad global network, HCL delivers holistic services in various industry verticals, including Financial Services, Manufacturing, Technology and Services, Telecom and Media, Retail and CPG, Life Sciences and Healthcare, and Public Services.
As a leading global technology company, HCL takes pride in its diversity, social responsibility, sustainability, and education initiatives. For the 12 months ended September 30, 2021, HCL had consolidated revenue of $10.82 billion. Its more than 187,000 ideapreneurs operate out of 50 countries.
For more information, visit www.hcltech.com
Innovaccer Inc., the Health Cloud company, is a leading San Francisco-based healthcare technology company committed to helping healthcare care as one. The InnovaccerⓇ Health Cloud unifies patient data across systems and settings, and empowers healthcare organizations to rapidly develop scalable, modern applications that improve clinical, operational, and financial outcomes. Innovaccer’s solutions have been deployed across more than 1,000 care settings in the U.S., enabling more than 37,000 providers to transform care delivery and work collaboratively with payers and life sciences companies. Innovaccer has helped organizations integrate medical records for more than 24 million people and generate more than $600 million in savings. Innovaccer is recognized as a Best in KLAS vendor for 2021 in population health management and is the No. 1 customer-rated vendor by Black Book. For more information, please visit innovaccer.com.
Certain statements in this release are forward-looking statements, which involve several risks, uncertainties, assumptions, and other factors that could cause actual results to differ materially from those in such forward-looking statements. All statements, other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to the statements containing the words “planned,” “expects,” “believes,” “strategy,” “opportunity,” “anticipates,” “hopes,” or other similar words. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding impact of pending regulatory proceedings, fluctuations in earnings, our ability to manage growth, intense competition in IT services, business process outsourcing and consulting services including those factors which may affect our cost advantage, wage increases in India, customer acceptances of our services, products and fee structures, our ability to attract and retain highly skilled professionals, our ability to integrate acquired assets in a cost-effective and timely manner, time and cost overruns on fixed-price, fixed-timeframe contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, the success of our brand development efforts, liability for damages on our service contracts, the success of the companies /entities in which we have made strategic investments, withdrawal of governmental fiscal incentives, political instability, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property, other risks, uncertainties and general economic conditions affecting our industry. There can be no assurance that the forward-looking statements made herein will prove to be accurate, and issuance of such forward-looking statements should not be regarded as a representation by the company, or any other person, that the objective and plans of the company will be achieved. All forward-looking statements made herein are based on information presently available to the management of the company and the company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the company.
For further details, please contact:
Meenakshi Benjwal, Americas
Dipshikha Bhattacharyya, EMEA
Devneeta Pahuja, India and APAC